| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.89 | 0.002 | 0.918 | 5 Hydroxytryptamine uptake inhibitor | 0.794 0.003 CID_10504397 0.918 0.002 CID_401916 | CID_401916 | |
| 0.769 | 0.003 | 0.769 | Sigma 1 receptor antagonist | 0.683 0.003 CID_10504397 0.536 0.004 CID_401916 | ||
| 0.769 | 0.003 | 0.769 | Sigma receptor antagonist | 0.661 0.004 CID_10504397 0.567 0.004 CID_401916 | ||
| 0.76 | 0.002 | 0.785 | Dopamine uptake inhibitor | 0.652 0.003 CID_10504397 0.785 0.002 CID_401916 | CID_401916 | |
| 0.751 | 0.003 | 0.751 | Histamine H1 receptor antagonist | 0.559 0.004 CID_10504397 0.701 0.003 CID_401916 | ||
| 0.704 | 0.004 | 0.704 | Antihistaminic | 0.441 0.005 CID_10504397 0.548 0.004 CID_401916 | ||
| 0.7 | 0.004 | 0.7 | Histamine antagonist | 0.421 0.005 CID_10504397 0.525 0.004 CID_401916 | ||
| 0.697 | 0.004 | 0.697 | 5 Hydroxytryptamine 2 antagonist | 0.57 0.005 CID_10504397 0.632 0.004 CID_401916 | ||
| 0.688 | 0.007 | 0.872 | Spasmolytic | 0.715 0.005 CID_10504397 0.872 0.004 CID_401916 | CID_401916 | |
| 0.649 | 0.003 | 0.649 | 5 Hydroxytryptamine 2A antagonist | 0.522 0.004 CID_10504397 0.566 0.004 CID_401916 | ||
| 0.619 | 0.014 | 0.653 | Vasodilator, peripheral | 0.626 0.013 CID_10504397 0.653 0.01 CID_401916 | CID_401916 | |
| 0.607 | 0.002 | 0.607 | Dopamine transporter inhibitor | 0.485 0.003 CID_10504397 0.591 0.002 CID_401916 | ||
| 0.604 | 0.004 | 0.604 | 5 Hydroxytryptamine 2C antagonist | 0.42 0.005 CID_10504397 0.334 0.008 CID_401916 | ||
| 0.597 | 0.005 | 0.597 | 5 Hydroxytryptamine antagonist | 0.388 0.012 CID_10504397 0.508 0.007 CID_401916 | ||
| 0.578 | 0.008 | 0.578 | Anticonvulsant | 0.362 0.027 CID_10504397 0.306 0.039 CID_401916 | ||
| 0.567 | 0.004 | 0.567 | 5 Hydroxytryptamine 2B antagonist | 0.44 0.007 CID_10504397 0.41 0.008 CID_401916 | ||
| 0.549 | 0.006 | 0.549 | Sigma receptor agonist | 0.521 0.008 CID_10504397 0.186 0.067 CID_401916 | ||
| 0.546 | 0.012 | 0.546 | HERG channel blocker | 0.333 0.041 CID_10504397 0.323 0.043 CID_401916 | ||
| 0.521 | 0.013 | 0.521 | Potassium channel (Voltage-sensitive) blocker | 0.32 0.044 CID_10504397 0.314 0.045 CID_401916 | ||
| 0.507 | 0.01 | 0.507 | Potassium channel blocker | 0.324 0.039 CID_10504397 0.382 0.026 CID_401916 | ||
| 0.499 | 0.004 | 0.499 | Calcium channel blocker | 0.353 0.006 CID_10504397 0.415 0.005 CID_401916 | ||
| 0.499 | 0.004 | 0.534 | Acetylcholine M1 receptor antagonist | 0.493 0.004 CID_10504397 0.534 0.004 CID_401916 | CID_401916 | |
| 0.473 | 0.005 | 0.473 | Nav1.2 sodium channel blocker | 0.377 0.008 CID_10504397 0.267 0.019 CID_401916 | ||
| 0.473 | 0.005 | 0.473 | Dopamine D2 antagonist | 0.44 0.006 CID_10504397 0.301 0.01 CID_401916 | ||
| 0.46 | 0.005 | 0.495 | 5 Hydroxytryptamine 1A antagonist | 0.345 0.007 CID_10504397 0.495 0.004 CID_401916 | CID_401916 | |
| 0.456 | 0.004 | 0.509 | Adrenaline uptake inhibitor | 0.342 0.004 CID_10504397 0.509 0.003 CID_401916 | CID_401916 | |
| 0.456 | 0.006 | 0.456 | Dopamine antagonist | 0.42 0.007 CID_10504397 0.283 0.012 CID_401916 | ||
| 0.453 | 0.005 | 0.453 | 5 Hydroxytryptamine 1 antagonist | 0.317 0.009 CID_10504397 0.431 0.005 CID_401916 | ||
| 0.448 | 0.004 | 0.53 | Acetylcholine muscarinic antagonist | 0.441 0.004 CID_10504397 0.53 0.004 CID_401916 | CID_401916 | |
| 0.443 | 0.006 | 0.494 | Cholinergic antagonist | 0.42 0.007 CID_10504397 0.494 0.005 CID_401916 | CID_401916 | |
| 0.436 | 0.004 | 0.436 | Nav1.3 sodium channel blocker | 0.333 0.007 CID_10504397 0.373 0.005 CID_401916 | ||
| 0.433 | 0.006 | 0.481 | Acetylcholine antagonist | 0.41 0.007 CID_10504397 0.481 0.005 CID_401916 | CID_401916 | |
| 0.446 | 0.037 | 0.448 | 5 Hydroxytryptamine release stimulant | 0.448 0.036 CID_10504397 | CID_10504397 | |
| 0.413 | 0.005 | 0.413 | 5 Hydroxytryptamine 1 agonist | 0.251 0.008 CID_10504397 0.083 0.024 CID_401916 | ||
| 0.452 | 0.049 | 0.497 | Histamine release inhibitor | 0.497 0.03 CID_10504397 0.468 0.041 CID_401916 | CID_10504397 | |
| 0.4 | 0.004 | 0.4 | Calcium channel (voltage-sensitive) blocker | 0.249 0.01 CID_10504397 0.155 0.031 CID_401916 | ||
| 0.389 | 0.005 | 0.389 | Dopamine agonist | 0.36 0.005 CID_10504397 0.242 0.007 CID_401916 | ||
| 0.388 | 0.01 | 0.455 | Alpha adrenoreceptor antagonist | 0.317 0.014 CID_10504397 0.455 0.007 CID_401916 | CID_401916 | |
| 0.371 | 0.005 | 0.371 | Alpha 2b adrenoreceptor antagonist | 0.309 0.009 CID_10504397 0.309 0.009 CID_401916 | ||
| 0.367 | 0.003 | 0.367 | Sigma 2 receptor antagonist | 0.327 0.003 CID_10504397 0.182 0.004 CID_401916 | ||
| 0.357 | 0.005 | 0.467 | Dopamine D1 antagonist | 0.467 0.004 CID_10504397 0.384 0.004 CID_401916 | CID_10504397 | |
| 0.361 | 0.008 | 0.603 | Anesthetic local | 0.311 0.011 CID_10504397 0.603 0.004 CID_401916 | CID_401916 | |
| 0.369 | 0.028 | 0.369 | Psychostimulant | 0.348 0.032 CID_10504397 0.326 0.036 CID_401916 | ||
| 0.346 | 0.005 | 0.346 | Nav1.6 sodium channel blocker | 0.272 0.008 CID_10504397 0.242 0.01 CID_401916 | ||
| 0.343 | 0.009 | 0.343 | Antipruritic | 0.334 0.01 CID_10504397 0.253 0.024 CID_401916 | ||
| 0.342 | 0.009 | 0.396 | Alpha 1 adrenoreceptor antagonist | 0.266 0.013 CID_10504397 0.396 0.007 CID_401916 | CID_401916 | |
| 0.331 | 0.006 | 0.331 | Nav1.1 sodium channel blocker | 0.304 0.008 CID_10504397 0.261 0.011 CID_401916 | ||
| 0.362 | 0.049 | 0.403 | Vasodilator, coronary | 0.371 0.046 CID_10504397 0.403 0.034 CID_401916 | CID_401916 | |
| 0.309 | 0.007 | 0.398 | Mediator release inhibitor | 0.398 0.005 CID_10504397 0.227 0.011 CID_401916 | CID_10504397 | |
| 0.322 | 0.026 | 0.322 | Ca(v)3.3 blocker | 0.27 0.073 CID_10504397 0.243 0.111 CID_401916 | ||
| 0.342 | 0.055 | 0.351 | Calcium channel activator | 0.326 0.067 CID_10504397 0.351 0.049 CID_401916 | CID_401916 | |
| 0.323 | 0.038 | 0.359 | Interleukin agonist | 0.314 0.041 CID_10504397 0.359 0.027 CID_401916 | CID_401916 | |
| 0.277 | 0.006 | 0.34 | Alpha 1d adrenoreceptor antagonist | 0.2 0.01 CID_10504397 0.34 0.005 CID_401916 | CID_401916 | |
| 0.278 | 0.015 | 0.473 | Antiadrenergic | 0.226 0.02 CID_10504397 0.473 0.006 CID_401916 | CID_401916 | |
| 0.268 | 0.006 | 0.268 | 5 Hydroxytryptamine 1A agonist | 0.121 0.013 CID_10504397 0.107 0.014 CID_401916 | ||
| 0.276 | 0.015 | 0.472 | Adrenaline antagonist | 0.224 0.02 CID_10504397 0.472 0.006 CID_401916 | CID_401916 | |
| 0.26 | 0.004 | 0.302 | Acetylcholine M5 receptor antagonist | 0.222 0.004 CID_10504397 0.302 0.003 CID_401916 | CID_401916 | |
| 0.266 | 0.01 | 0.266 | 5 Hydroxytryptamine agonist | 0.132 0.025 CID_10504397 0.061 0.054 CID_401916 | ||
| 0.261 | 0.007 | 0.261 | Dopamine D3 antagonist | 0.21 0.01 CID_10504397 0.152 0.015 CID_401916 | ||
| 0.253 | 0.004 | 0.253 | Calcium channel T-type blocker | 0.15 0.007 CID_10504397 0.067 0.03 CID_401916 | ||
| 0.313 | 0.08 | 0.375 | Antithrombotic | 0.339 0.068 CID_10504397 0.375 0.056 CID_401916 | CID_401916 | |
| 0.236 | 0.005 | 0.236 | Interferon agonist | 0.201 0.006 CID_10504397 0.165 0.009 CID_401916 | ||
| 0.242 | 0.013 | 0.242 | Alpha 1a adrenoreceptor antagonist | 0.174 0.02 CID_10504397 0.238 0.013 CID_401916 | ||
| 0.238 | 0.009 | 0.238 | Calcium antagonist | 0.13 0.03 CID_10504397 0.132 0.029 CID_401916 | ||
| 0.237 | 0.01 | 0.237 | Dopamine D4 antagonist | 0.18 0.014 CID_10504397 0.153 0.017 CID_401916 | ||
| 0.236 | 0.01 | 0.236 | Calcium channel N-type blocker | 0.16 0.032 CID_10504397 0.116 0.069 CID_401916 | ||
| 0.233 | 0.013 | 0.233 | Alpha 2 adrenoreceptor antagonist | 0.195 0.018 CID_10504397 0.226 0.014 CID_401916 | ||
| 0.282 | 0.064 | 0.284 | Cardiotonic | 0.235 0.092 CID_10504397 0.284 0.063 CID_401916 | CID_401916 | |
| 0.306 | 0.088 | 0.396 | Cholesterol antagonist | 0.367 0.058 CID_10504397 0.396 0.05 CID_401916 | CID_401916 | |
| 0.22 | 0.005 | 0.22 | Calcium channel L-type blocker | 0.154 0.009 CID_10504397 0.115 0.018 CID_401916 | ||
| 0.217 | 0.012 | 0.217 | Alpha 2a adrenoreceptor antagonist | 0.194 0.015 CID_10504397 0.179 0.017 CID_401916 | ||
| 0.209 | 0.006 | 0.252 | Acetylcholine M3 receptor antagonist | 0.247 0.005 CID_10504397 0.252 0.005 CID_401916 | CID_401916 | |
| 0.209 | 0.008 | 0.266 | Sphingomyelinase inhibitor | 0.187 0.012 CID_10504397 0.266 0.004 CID_401916 | CID_401916 | |
| 0.204 | 0.005 | 0.204 | Histamine H3 receptor antagonist | 0.062 0.021 CID_10504397 0.041 0.033 CID_401916 | ||
| 0.203 | 0.005 | 0.203 | Histamine H2 receptor antagonist | 0.145 0.011 CID_10504397 0.125 0.018 CID_401916 | ||
| 0.252 | 0.063 | 0.274 | Cyclic AMP phosphodiesterase inhibitor | 0.263 0.057 CID_10504397 0.274 0.053 CID_401916 | CID_401916 | |
| 0.203 | 0.017 | 0.203 | Alpha 2c adrenoreceptor antagonist | 0.169 0.025 CID_10504397 0.188 0.02 CID_401916 | ||
| 0.343 | 0.159 | 0.343 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.288 0.229 CID_401916 | ||
| 0.255 | 0.076 | 0.255 | 5 Hydroxytryptamine uptake stimulant | 0.248 0.083 CID_10504397 | ||
| 0.217 | 0.04 | 0.217 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.126 CID_10504397 0.167 0.148 CID_401916 | ||
| 0.178 | 0.004 | 0.178 | Interferon inducer | 0.152 0.005 CID_10504397 0.134 0.005 CID_401916 | ||
| 0.186 | 0.016 | 0.229 | Alpha 1b adrenoreceptor antagonist | 0.146 0.023 CID_10504397 0.229 0.012 CID_401916 | CID_401916 | |
| 0.178 | 0.015 | 0.178 | 5 Hydroxytryptamine 7 antagonist | 0.087 0.028 CID_10504397 0.086 0.029 CID_401916 | ||
| 0.188 | 0.026 | 0.286 | Interleukin 4 antagonist | 0.245 0.014 CID_10504397 0.286 0.009 CID_401916 | CID_401916 | |
| 0.164 | 0.009 | 0.181 | Acetylcholine M2 receptor antagonist | 0.146 0.012 CID_10504397 0.181 0.008 CID_401916 | CID_401916 | |
| 0.157 | 0.009 | 0.157 | Dopamine D4 agonist | 0.088 0.017 CID_10504397 0.064 0.025 CID_401916 | ||
| 0.146 | 0.002 | 0.146 | GABA uptake inhibitor | 0.129 0.003 CID_10504397 0.126 0.003 CID_401916 | ||
| 0.15 | 0.01 | 0.15 | Acetylcholine M4 receptor antagonist | 0.095 0.033 CID_10504397 0.129 0.015 CID_401916 | ||
| 0.161 | 0.021 | 0.161 | Multidrug resistance-associated protein 1 inhibitor | 0.152 0.024 CID_10504397 | ||
| 0.149 | 0.014 | 0.149 | Histamine N-methyltransferase inhibitor | 0.141 0.018 CID_10504397 | ||
| 0.205 | 0.072 | 0.256 | Neurotrophic factor enhancer | 0.256 0.035 CID_10504397 | CID_10504397 | |
| 0.14 | 0.008 | 0.205 | Glycine transporter 2 inhibitor | 0.205 0.005 CID_10504397 0.049 0.031 CID_401916 | CID_10504397 | |
| 0.145 | 0.014 | 0.145 | Glutamate (mGluR7) agonist | 0.105 0.051 CID_10504397 0.142 0.015 CID_401916 | ||
| 0.192 | 0.069 | 0.194 | P-glycoprotein inhibitor | 0.194 0.068 CID_10504397 0.175 0.085 CID_401916 | CID_10504397 | |
| 0.118 | 0.004 | 0.118 | 5 Hydroxytryptamine 1D agonist | 0.06 0.008 CID_10504397 | ||
| 0.123 | 0.011 | 0.123 | 5 Hydroxytryptamine 5A antagonist | 0.089 0.019 CID_10504397 | ||
| 0.156 | 0.052 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.153 0.056 CID_10504397 | ||
| 0.25 | 0.148 | 0.28 | Immunosuppressant | 0.28 0.128 CID_10504397 0.252 0.146 CID_401916 | CID_10504397 | |
| 0.103 | 0.004 | 0.13 | Cytokine production stimulant | 0.072 0.007 CID_10504397 0.13 0.003 CID_401916 | CID_401916 | |
| 0.112 | 0.013 | 0.112 | 5 Hydroxytryptamine 5 antagonist | 0.075 0.023 CID_10504397 | ||
| 0.195 | 0.098 | 0.306 | Hypolipemic | 0.207 0.089 CID_10504397 0.306 0.047 CID_401916 | CID_401916 | |
| 0.117 | 0.027 | 0.215 | Adrenaline agonist | 0.179 0.009 CID_10504397 0.215 0.005 CID_401916 | CID_401916 | |
| 0.163 | 0.073 | 0.179 | Arachidonic acid antagonist | 0.179 0.055 CID_10504397 0.137 0.104 CID_401916 | CID_10504397 | |
| 0.099 | 0.011 | 0.117 | Dopamine D2 agonist | 0.117 0.009 CID_10504397 0.069 0.017 CID_401916 | CID_10504397 | |
| 0.261 | 0.173 | 0.261 | Analgesic | 0.244 0.188 CID_10504397 0.247 0.185 CID_401916 | ||
| 0.117 | 0.031 | 0.117 | Acetylcholine nicotinic antagonist | 0.089 0.046 CID_10504397 | ||
| 0.208 | 0.122 | 0.261 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.059 CID_10504397 | CID_10504397 | |
| 0.108 | 0.023 | 0.247 | Estrogen receptor alpha antagonist | 0.247 0.006 CID_10504397 0.118 0.019 CID_401916 | CID_10504397 | |
| 0.136 | 0.052 | 0.175 | Cholesterol synthesis inhibitor | 0.175 0.034 CID_10504397 0.122 0.063 CID_401916 | CID_10504397 | |
| 0.114 | 0.031 | 0.119 | Phosphodiesterase 6D inhibitor | 0.119 0.026 CID_10504397 0.106 0.042 CID_401916 | CID_10504397 | |
| 0.138 | 0.058 | 0.138 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.058 CID_10504397 | ||
| 0.089 | 0.011 | 0.089 | Ca(v)3.2 blocker | 0.077 0.017 CID_10504397 0.059 0.041 CID_401916 | ||
| 0.143 | 0.065 | 0.17 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.17 0.052 CID_10504397 | CID_10504397 | |
| 0.151 | 0.073 | 0.182 | Phospholipase A2 inhibitor | 0.182 0.053 CID_10504397 0.158 0.067 CID_401916 | CID_10504397 | |
| 0.093 | 0.018 | 0.114 | NMDA 2C receptor antagonist | 0.114 0.012 CID_10504397 0.095 0.018 CID_401916 | CID_10504397 | |
| 0.105 | 0.03 | 0.116 | Myeloperoxidase inhibitor | 0.116 0.022 CID_10504397 | CID_10504397 | |
| 0.084 | 0.011 | 0.141 | Dopamine D5 antagonist | 0.09 0.01 CID_10504397 0.141 0.007 CID_401916 | CID_401916 | |
| 0.101 | 0.031 | 0.167 | NMDA 2 receptor antagonist | 0.167 0.013 CID_10504397 0.068 0.053 CID_401916 | CID_10504397 | |
| 0.095 | 0.026 | 0.095 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.078 | 0.012 | 0.078 | Potassium channel Kv1.3 blocker | 0.077 0.013 CID_10504397 | ||
| 0.139 | 0.076 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 CID_10504397 0.147 0.052 CID_401916 | CID_401916 | |
| 0.07 | 0.008 | 0.082 | Dopamine beta hydroxylase inhibitor | 0.082 0.005 CID_10504397 | CID_10504397 | |
| 0.107 | 0.046 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | 0.102 0.053 CID_10504397 0.098 0.059 CID_401916 | ||
| 0.091 | 0.034 | 0.1 | CC chemokine 5 receptor agonist | 0.1 0.022 CID_10504397 | CID_10504397 | |
| 0.086 | 0.029 | 0.086 | Acetylcholine M5 receptor agonist | |||
| 0.072 | 0.016 | 0.072 | 5 Hydroxytryptamine 1B agonist | 0.057 0.03 CID_10504397 | ||
| 0.132 | 0.078 | 0.132 | Neurotrophic factor | 0.131 0.079 CID_10504397 | ||
| 0.071 | 0.018 | 0.071 | Histamine agonist | |||
| 0.194 | 0.142 | 0.194 | MAP kinase kinase 3 inhibitor | 0.183 0.179 CID_401916 | ||
| 0.074 | 0.022 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.086 | 0.039 | 0.086 | 5 Hydroxytryptamine 1F antagonist | 0.069 0.051 CID_401916 | ||
| 0.068 | 0.022 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 CID_10504397 0.073 0.015 CID_401916 | CID_10504397 | |
| 0.26 | 0.215 | 0.281 | 5 Hydroxytryptamine release inhibitor | 0.281 0.187 CID_10504397 | CID_10504397 | |
| 0.049 | 0.005 | 0.058 | Calcium-sensing receptor antagonist | 0.037 0.005 CID_10504397 0.058 0.005 CID_401916 | CID_401916 | |
| 0.113 | 0.068 | 0.186 | Estrogen antagonist | 0.186 0.015 CID_10504397 0.119 0.056 CID_401916 | CID_10504397 | |
| 0.087 | 0.044 | 0.087 | T cell inhibitor | 0.081 0.063 CID_10504397 | ||
| 0.063 | 0.019 | 0.063 | Oleamide hydrolase inhibitor | 0.043 0.033 CID_10504397 | ||
| 0.134 | 0.092 | 0.184 | NOS3 expression enhancer | 0.184 0.048 CID_10504397 | CID_10504397 | |
| 0.059 | 0.02 | 0.059 | Histamine H4 receptor antagonist | |||
| 0.054 | 0.017 | 0.054 | Dopamine D3 agonist | 0.051 0.019 CID_10504397 0.039 0.028 CID_401916 | ||
| 0.083 | 0.046 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.047 | 0.011 | 0.113 | Prostaglandin agonist | 0.05 0.01 CID_10504397 0.113 0.005 CID_401916 | CID_401916 | |
| 0.06 | 0.026 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.169 | 0.135 | 0.177 | ErbB-1 antagonist | 0.177 0.121 CID_10504397 | CID_10504397 | |
| 0.052 | 0.019 | 0.052 | Leukotriene A4 hydrolase inhibitor | 0.043 0.024 CID_10504397 | ||
| 0.064 | 0.032 | 0.072 | Sphingosine kinase inhibitor | 0.072 0.022 CID_10504397 | CID_10504397 | |
| 0.039 | 0.007 | 0.09 | Prostaglandin E2 agonist | 0.041 0.007 CID_10504397 0.09 0.004 CID_401916 | CID_401916 | |
| 0.088 | 0.056 | 0.146 | NMDA receptor antagonist | 0.146 0.026 CID_10504397 0.103 0.045 CID_401916 | CID_10504397 | |
| 0.04 | 0.008 | 0.056 | Prostaglandin EP2 agonist | 0.04 0.008 CID_10504397 0.056 0.005 CID_401916 | CID_401916 | |
| 0.061 | 0.03 | 0.069 | Sphingosine kinase 2 inhibitor | 0.069 0.022 CID_10504397 | CID_10504397 | |
| 0.043 | 0.014 | 0.059 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 CID_10504397 0.059 0.004 CID_401916 | CID_401916 | |
| 0.044 | 0.016 | 0.044 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.025 CID_10504397 | ||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | 0.056 0.035 CID_10504397 | ||
| 0.049 | 0.022 | 0.049 | Histamine H2 receptor agonist | |||
| 0.055 | 0.029 | 0.055 | Potassium channel (Inward rectifier) blocker | 0.052 0.032 CID_401916 | ||
| 0.091 | 0.07 | 0.161 | Creatine kinase inhibitor | 0.161 0.02 CID_10504397 0.095 0.065 CID_401916 | CID_10504397 | |
| 0.15 | 0.129 | 0.15 | Platelet aggregation inhibitor | |||
| 0.096 | 0.076 | 0.12 | Toll-Like receptor 4 antagonist | 0.12 0.044 CID_10504397 | CID_10504397 | |
| 0.044 | 0.025 | 0.044 | Heme oxygenase inhibitor | 0.041 0.037 CID_401916 | ||
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | 0.067 0.06 CID_401916 | ||
| 0.044 | 0.024 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.023 CID_10504397 | CID_10504397 | |
| 0.038 | 0.019 | 0.038 | Prostacyclin antagonist | 0.034 0.022 CID_10504397 | ||
| 0.052 | 0.034 | 0.052 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.115 | 0.1 | 0.131 | Vanilloid 1 agonist | 0.131 0.065 CID_10504397 | CID_10504397 | |
| 0.036 | 0.021 | 0.038 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.038 0.019 CID_10504397 | CID_10504397 | |
| 0.063 | 0.049 | 0.083 | Beta 3 adrenoreceptor antagonist | 0.083 0.021 CID_10504397 0.083 0.021 CID_401916 | CID_401916 | |
| 0.107 | 0.094 | 0.161 | Toll-Like receptor 2 antagonist | 0.161 0.045 CID_10504397 | CID_10504397 | |
| 0.031 | 0.019 | 0.034 | Potassium channel (Inward rectifier) 1 blocker | 0.034 0.012 CID_401916 | CID_401916 | |
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.077 | 0.067 | 0.077 | Caspase 7 inhibitor | |||
| 0.054 | 0.044 | 0.128 | Alpha 1 adrenoreceptor agonist | 0.128 0.012 CID_401916 | CID_401916 | |
| 0.044 | 0.036 | 0.055 | Beta adrenoreceptor agonist | 0.055 0.011 CID_10504397 0.049 0.019 CID_401916 | CID_10504397 | |
| 0.139 | 0.132 | 0.147 | Non-steroidal antiinflammatory agent | 0.147 0.118 CID_10504397 0.142 0.126 CID_401916 | CID_10504397 | |
| 0.061 | 0.054 | 0.096 | Beta adrenoreceptor antagonist | 0.084 0.024 CID_10504397 0.096 0.018 CID_401916 | CID_401916 | |
| 0.054 | 0.047 | 0.057 | Pregnane X receptor antagonist | 0.053 0.05 CID_10504397 0.057 0.038 CID_401916 | CID_401916 | |
| 0.05 | 0.044 | 0.069 | Alpha-mannosidase inhibitor | 0.05 0.045 CID_10504397 0.069 0.018 CID_401916 | CID_401916 | |
| 0.09 | 0.084 | 0.149 | Estrogen receptor beta antagonist | 0.149 0.016 CID_10504397 0.101 0.062 CID_401916 | CID_10504397 | |
| 0.073 | 0.067 | 0.073 | Acetylcholine M3 receptor agonist | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | |||
| 0.017 | 0.013 | 0.017 | CXC chemokine 5 receptor antagonist | |||
| 0.072 | 0.069 | 0.072 | Viral attachment inhibitor | |||
| 0.05 | 0.048 | 0.05 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.055 | 0.054 | 0.055 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.083 | 0.082 | 0.083 | MAP kinase kinase 1 inhibitor | |||
| 0.058 | 0.059 | 0.076 | Leukotriene synthesis inhibitor | 0.076 0.04 CID_10504397 | CID_10504397 | |
| 0.092 | 0.094 | 0.134 | DOPA decarboxylase inhibitor | 0.134 0.032 CID_10504397 | CID_10504397 | |
| 0.042 | 0.045 | 0.066 | NMDA 2A receptor antagonist | 0.066 0.026 CID_10504397 0.047 0.041 CID_401916 | CID_10504397 | |
| 0.039 | 0.043 | 0.056 | Mannosidase inhibitor | 0.056 0.02 CID_401916 | CID_401916 | |
| 0.047 | 0.052 | 0.06 | Leukotriene B4 antagonist | 0.056 0.034 CID_10504397 0.06 0.027 CID_401916 | CID_401916 | |
| 0.07 | 0.077 | 0.098 | Opioid kappa receptor antagonist | 0.098 0.037 CID_10504397 | CID_10504397 | |
| 0.083 | 0.092 | 0.096 | Ferrochelatase inhibitor | 0.096 0.075 CID_401916 | CID_401916 | |
| 0.04 | 0.052 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 CID_10504397 0.056 0.028 CID_401916 | CID_10504397 | |
| 0.159 | 0.171 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 CID_10504397 | CID_10504397 | |
| 0.064 | 0.078 | 0.13 | Macrophage migration inhibitory factor inhibitor | 0.13 0.022 CID_10504397 | CID_10504397 | |
| 0.024 | 0.038 | 0.046 | Cholesterol ester transfer protein antagonist | 0.046 0.009 CID_401916 | CID_401916 | |
| 0.053 | 0.067 | 0.146 | Alpha adrenoreceptor agonist | 0.146 0.017 CID_401916 | CID_401916 | |
| 0.024 | 0.038 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.013 CID_10504397 | CID_10504397 | |
| 0.045 | 0.064 | 0.053 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 CID_401916 | CID_401916 | |
| 0.192 | 0.212 | 0.306 | Toll-Like receptor 7 agonist | 0.306 0.106 CID_401916 | CID_401916 | |
| 0.159 | 0.182 | 0.178 | Nitric-oxide synthase stimulant | 0.178 0.133 CID_10504397 0.173 0.144 CID_401916 | CID_10504397 | |
| 0.19 | 0.215 | 0.3 | Toll-Like receptor agonist | 0.3 0.111 CID_401916 | CID_401916 | |
| 0.135 | 0.163 | 0.151 | Platelet antagonist | 0.151 0.143 CID_401916 | CID_401916 | |
| 0.238 | 0.268 | 0.298 | Caspase 9 stimulant | 0.298 0.196 CID_10504397 | CID_10504397 | |
| 0.02 | 0.051 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 CID_401916 | CID_401916 | |
| 0.077 | 0.113 | 0.099 | Adenylate cyclase inhibitor | 0.099 0.085 CID_10504397 | CID_10504397 | |
| 0.035 | 0.076 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.055 0.04 CID_10504397 0.056 0.04 CID_401916 | CID_401916 | |
| 0.012 | 0.057 | 0.024 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 CID_401916 | CID_401916 | |
| 0.163 | 0.21 | 0.259 | Transcription factor NF kappa B inhibitor | 0.259 0.121 CID_10504397 | CID_10504397 | |
| 0.117 | 0.164 | 0.141 | MAP kinase kinase 4 inhibitor | 0.141 0.081 CID_10504397 | CID_10504397 | |
| 0.035 | 0.089 | 0.051 | NMDA 2B receptor antagonist | 0.051 0.041 CID_10504397 | CID_10504397 | |
| 0.118 | 0.179 | 0.144 | Insulin sensitizer | 0.144 0.142 CID_10504397 | CID_10504397 | |
| 0.116 | 0.179 | 0.234 | Aldehyde oxidase inhibitor | 0.234 0.089 CID_10504397 | CID_10504397 | |
| 0.055 | 0.12 | 0.09 | Opioid antagonist | 0.09 0.057 CID_10504397 | CID_10504397 | |
| 0.021 | 0.085 | 0.036 | Dopamine D5 agonist | 0.036 0.033 CID_10504397 | CID_10504397 | |
| 0.107 | 0.172 | 0.131 | Interferon gamma antagonist | 0.131 0.108 CID_10504397 | CID_10504397 | |
| 0.013 | 0.079 | 0.043 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.043 0.019 CID_10504397 | CID_10504397 | |
| 0.145 | 0.214 | 0.17 | DNA synthesis inhibitor | 0.17 0.168 CID_10504397 | CID_10504397 | |
| 0.088 | 0.158 | 0.128 | Antibacterial (Helicobacter pylori) | 0.128 0.07 CID_401916 | CID_401916 | |
| 0.118 | 0.192 | 0.174 | Antiamyloidogenic | 0.174 0.119 CID_10504397 0.17 0.123 CID_401916 | CID_10504397 | |
| 0.123 | 0.203 | 0.156 | Vasodilator | 0.156 0.148 CID_10504397 0.156 0.148 CID_401916 | CID_401916 | |
| 0.076 | 0.156 | 0.105 | Aldehyde dehydrogenase inhibitor | 0.105 0.09 CID_10504397 | CID_10504397 | |
| 0.031 | 0.113 | 0.062 | Opioid mu receptor antagonist | 0.062 0.052 CID_10504397 | CID_10504397 | |
| 0.067 | 0.151 | 0.117 | Beta amyloid protein antagonist | 0.117 0.071 CID_401916 | CID_401916 | |
| 0.075 | 0.161 | 0.162 | Lipid peroxidase inhibitor | 0.162 0.061 CID_10504397 | CID_10504397 | |
| 0.194 | 0.284 | 0.447 | Calcium channel L-type activator | 0.321 0.14 CID_10504397 0.447 0.052 CID_401916 | CID_401916 | |
| 0.049 | 0.146 | 0.114 | Urease inhibitor | 0.114 0.051 CID_401916 | CID_401916 | |
| 0.13 | 0.231 | 0.219 | Lipoxygenase inhibitor | 0.219 0.122 CID_10504397 | CID_10504397 | |
| 0.158 | 0.275 | 0.233 | Interleukin 2 agonist | 0.214 0.166 CID_10504397 0.233 0.139 CID_401916 | CID_401916 | |
| 0.117 | 0.242 | 0.182 | Hypoglycemic | 0.182 0.131 CID_10504397 | CID_10504397 | |
| 0.009 | 0.16 | 0.049 | Estrogen agonist | 0.049 0.036 CID_10504397 | CID_10504397 | |
| 0.075 | 0.229 | 0.127 | MAP3K9 inhibitor | 0.127 0.101 CID_401916 | CID_401916 | |
| 0.12 | 0.276 | 0.246 | Hypoxia-inducible factor 1 alpha inhibitor | 0.183 0.175 CID_10504397 0.246 0.104 CID_401916 | CID_401916 | |
| 0.009 | 0.165 | 0.063 | Prostaglandin D2 agonist | 0.063 0.005 CID_401916 | CID_401916 | |
| 0.138 | 0.303 | 0.197 | Apoptosis antagonist | 0.197 0.184 CID_10504397 | CID_10504397 | |
| 0.054 | 0.237 | 0.096 | Toll-Like receptor 3 antagonist | 0.096 0.057 CID_401916 | CID_401916 | |
| 0.033 | 0.273 | 0.203 | Bronchodilator | 0.203 0.018 CID_401916 | CID_401916 | |
| 0.041 | 0.32 | 0.129 | Interleukin 5 antagonist | 0.129 0.019 CID_401916 | CID_401916 | |
| 0.089 | 0.395 | 0.224 | Antiobesity | 0.224 0.182 CID_401916 | CID_401916 | |
| 0.072 | 0.685 | 0.221 | Peptidyltransferase inhibitor | 0.221 0.075 CID_401916 | CID_401916 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |